Comparison of the conjunctival allergen challenge model with the environmental model of allergic conjunctivitis

Acta Ophthalmologica Scandinavica, Supplement

Volumn 77, Issue 228, 1999, Pages 38-42

  Abelson, Mark B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CROMOGLYCATE DISODIUM; HISTAMINE; IMMUNOGLOBULIN E RECEPTOR; LEVOCABASTINE; PLACEBO; TRYPTASE; ANTIALLERGIC AGENT;

ALLERGIC CONJUNCTIVITIS; ATOPY; BIOLOGICAL MODEL; CLINICAL FEATURE; COMPARATIVE STUDY; COMPLIANCE (PHYSICAL); CONFERENCE PAPER; CYTOLOGY; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; ENVIRONMENTAL EXPOSURE; EYELID EDEMA; HISTOLOGY; HOME MONITORING; HUMAN; HYPEREMIA; MAST CELL; MEDIATOR; MEDIATOR RELEASE; PATHOPHYSIOLOGY; POLLEN; PRIORITY JOURNAL; PROPHYLAXIS; PROVOCATION TEST; SEASONAL VARIATION; REVIEW;

ALLERGENS; ANTI-ALLERGIC AGENTS; CONJUNCTIVITIS, ALLERGIC; ENVIRONMENTAL EXPOSURE; HUMANS; MODELS, BIOLOGICAL;

EID: 0032586311     PISSN: 13953931     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.1999.tb01172.x     Document Type: Conference Paper

References (32)

1. Abelson MB & Allansmith MR (1979): Histamine and the eye. In: Silverstein A, O'Connor G, eds. Immunology and immunopathology of the eye. New York: Masson 362-364.
2. Abelson MB, Madiwale NA & Weston JH (1985): The role of prostaglandin D2 in allergic ocular disease. In: O'Connor GR, Chandler JW, eds. Advances in immunology and immunopathology of the eye. New York: Masson 163-166.
3. Abelson MB, Chambers WA & Smith LM (1990): Conjunctival allergen challenge: A clinical approach to studying allergic conjunctivitis. Arch Opthalmol 108: 84-88.
4. Abelson MB & Weintraub D (1994): Levocabastine eye drops: A new approach for the treatment of acute allergic conjunctivitis. Eur J Ophthalmol 4: 91-101.
5. Abelson MB, George MA & Smith LM (1995):Evaluation of 0.05% levocabastine versus 4% sodium cromolyn in the allergen challenge model. Ophthalmology 102: 310-316.
6. Abelson MB, et al. (1995): Histaminase activity in patients with vernal kerato-conjunctivitis. Ophthalmology 102: 1958-1963.
7. Abelson MB & Udell IJ (1981): H2 receptors in the human ocular surface. Arch Ophthalmol 99: 302-304.
8. Abelson MB. Multinational evaluation of the efficacy and safety of emedastine eye drops 0.05% in alleviating the signs and symptoms of seasonal allergic conjunctivitis. European Emadine Study Group (in press).
9. Allansmith MR, Greiner JV & Baird RS (1978): Number of inflammatory cells in the normal conjunctiva. Am J Ophthalmol 86: 250-259.
10. Allansmith MR, et al. (1979): Mast cells in ocular tissues of normal rats and rats infected with Nippostrongylus rasilicnsis. Invest Opthalmol Vis Sci 18: 858-863.
11. Allansmith MR (1982): Immunology of the eye. In: Allansmith MR, ed. The eye and immunology. St. Louis: CV Mosby, 99-115.
12. Arrange J, Garbarg M & Schwartz J (1983): Autoinhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 27: 832-837.
13. Ash A & Schild H (1966): Receptors mediating some actions of histamine. Br J Pharm 27: 427-439.
14. Berdy GJ, et al. (1990): Identification of histaminase activity in human tears after conjunctival antigen challenge. Invest Ophthalmol Vis Sci 31: 65 (abstr).
15. Black J, et al. (1972): Definition and antagonism of histamine 1-12-receptors. Nature 236:385.
16. Braquet P (1987): Perspectives in platelet-activating factor research. Agents Actions 15: 32-85.
17. Butrus SI, Abelson MB & Allansmith MR (1987): Ocular allergic disorders. In: Lockey RF, Bukantz SC, eds. Principles of immunology and allergy. Philadelphia: WB Saunders 165-176.
18. Butrus SI, et al. (1990): The level of tryptase in human tears: An indicator of conjunctival mast cells. Ophthalmology 97: 1678-1683.
19. Davis B, Mullins J (1993):. Topical levocabastine is more effective than sodium cromoglycate for the prophylaxis and treatment of seasonal allergic conjunctivitis. Allergy 48: 519-524.
20. Frostad A, Olsen A (1993): A comparison of topical levocabastine and sodium cromoglycate in the treatment of pollen-provoked allergic conjunctivitis. Clin Exp Allergy 23: 406-409.
21. George MA, et al. (1990): Platelet activating factor induced inflammation following topical ocular challenge. Invest Ophthalmol Vis Sci 31:63.
22. Hendrix S, et al. (1980): A multi-institutional trial of polymerized whole ragweed for immuunotherapy of ragweed allergy. J Allergy Clin Immunol 66: 486-494.
23. Kazdan J, et al. (1976): Sodium cromoglycate (Intal) in the treatment of vernal keratoconjunctivitis and allergic conjunctivitis. Can J Ophthalmol 11: 300-303.
24. Kinet JP. The high-affinity receptor for immunoglobulin-E: Structure, function, and role in allergy. In: Gallin J, Goldstein, Snyderman R, eds. Inflammation: Basic principles and clinical correlates. 2 ed. New York: Raven Press, 1992.
25. Levene R (1962): Mast cells and amines in normal ocular tissues. Invest Ophthalmol 1:531-543.
26. Lindsay-Miller A (1979): Group comparative trial of 2% sodium cromoglycate (Opticrom) with placebo in the treatment of seasonal allergic conjunctivitis. Clin Allergy 9: 271-275.
27. Lindsay-Miller A & Chambers WA (1987): Group comparative trial of cromolyn sodium and terfenadine in the treatment of seasonal allergic rhinitis. Ann Allergy 58: 28-32.
28. Odelram H, et al. (1989): Topical levocabastine versus sodium cromoglycate allergic conjunctivitis. Allergy 44: 432-436.
29. Prausnitz C, Kustner H (1921): Studien ueber die Ueberempfindlichkeit. Centra Bakteriol 86: 160.
30. Schechter N, et al. (1986): Identification of a chymotrypsin-like proteinase in human mast cells. J Immunol 137: 962-970.
31. Spada C, et al. (1986): Leukotrienes cause eosinophil emigration into conjunctival tissue. Prostaglandins 31: 795-809.
32. Tamura N, et al. (1986): Effects of platelet-activating factor on the chemotaxis of normodense eosinophils from normal subjects. Biochem Biophys Res Commun 142: 638-644.